mRNA levels of FLRT3 and SLC14A1 also showed a stepwise reduction from benign to primary prostate tumor and metastatic samples in other clinical prostate datasets (Supplementary Figure 11)[20–22, 25]. The gene discussed is FLRT3; the disease is prostate neoplasm.